申请人:Merrell Dow Pharmaceuticals Inc.
公开号:US05041554A1
公开(公告)日:1991-08-20
This invention relates to novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions.
这项发明涉及一种新型芳基或杂环芳基-1-烷基-吡咯烷-2-羧酸化合物,可用于治疗介导白细胞介素-1的疾病。